Business Context and Reporting Period
HCM III ACQUISITION CORP. (HCM III) is a Cayman Islands exempted corporation formed as a blank check company for the purpose of effecting a business combination. The company has not commenced operations and has not selected a specific target. This Form 10-Q covers the quarter and six months ended June 30, 2026. The company completed its Initial Public Offering (IPO) on August 4, 2025, raising $253 million, and must complete a business combination by August 4, 2027, or liquidate.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2026 | Three Months Ended June 30, 2026 |
|---|---|---|
| Net Income | $3,297,929 | $1,573,326 |
| General & Administrative Costs | $1,218,314 | $831,041 |
| Interest Income (Trust Account) | $4,501,349 | $2,397,984 |
| Trust Account Balance | $261,800,278 | $261,800,278 |
| Cash & Cash Equivalents (Outside Trust) | $670,656 | $670,656 |
| Working Capital Deficit | ($747,185) | N/A |
| Deferred Underwriting Fees | $12,045,000 | $12,045,000 |
| Accrued Expenses | $1,452,508 | $1,452,508 |
Per Share Data: Basic and diluted net income per ordinary share was $0.10 for the six months ended June 30, 2026, and $0.05 for the three months ended June 30, 2026, for both Class A and Class B shares.
Material Changes vs. Prior Period
- Profitability: The company reported a net income of $3.3 million for the six months ended June 30, 2026, compared to a net loss of $47,545 for the period from inception (April 15, 2025) through June 30, 2025. This shift is driven by significant interest income earned on the Trust Account following the IPO.
- Trust Account Growth: The Trust Account balance increased from $257.3 million at December 31, 2025, to $261.8 million at June 30, 2026, due to accrued interest income.
- Liquidity: Cash and cash equivalents outside the Trust Account decreased from $1.02 million at December 31, 2025, to $670,656 at June 30, 2026, reflecting operating cash usage.
- Liabilities: Accrued expenses increased significantly from $589,831 at December 31, 2025, to $1,452,508 at June 30, 2026.
Outlook, Risks, and Management Commentary
- Going Concern: Management has expressed substantial doubt about the company's ability to continue as a going concern for at least twelve months from the issuance date. The company must complete a business combination by August 4, 2027, or liquidate. Additional financing may be required to meet working capital needs.
- Capital Resources: The company has $670,656 in cash outside the Trust Account. The Sponsor and affiliates may provide working capital loans (up to $1.5 million convertible to warrants) but are not obligated to do so.
- Redemption Rights: Public shareholders may redeem their shares for a pro-rata share of the Trust Account upon the completion of a business combination or if the company fails to complete one within the specified timeframe. The redemption value was $10.35 per share as of June 30, 2026.
- Risks: Risks include the inability to complete a business combination, market volatility due to geopolitical conflicts (Russia-Ukraine, Israel-Hamas), and the potential inability to secure additional financing.
- Unusual Items: The company incurred $90,000 in administrative fees for the six months ended June 30, 2026, payable to a Sponsor affiliate. A deferred underwriting fee of $12.0 million is payable upon the completion of a business combination.
Investor Verification Checklist
- Liquidity Runway: Verify if the $670,656 cash balance outside the Trust Account is sufficient to fund operations until the August 4, 2027, deadline without additional Sponsor loans.
- Accrued Expenses: Investigate the composition of the $1.45 million in accrued expenses to understand immediate cash obligations.
- Trust Account Yield: Monitor the interest rate environment and its impact on the Trust Account balance, which directly affects the redemption price per share.
- Business Combination Progress: Confirm if the company has entered into any substantive discussions with potential targets, as none were reported as of the filing date.
- Deferred Fees: Note the $12.0 million deferred underwriting fee obligation that will reduce net proceeds upon a successful business combination.